Medical device recalls

LumiraDx recalls LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality Control Kit Catalog #: L016080109002 (EUA) The LumiraDx SARS-CoV-2 Qual…

Recall date
September 23, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0135-2023
FDA classification
Class III
Brand / firm
LumiraDx
Sold / distributed
US Nationwide distribution.

Why it was recalled

Assigned vial lot numbers for the incorrect type of product. SARS-CoV-2 & Flu A/B lot numbers were incorrectly assigned to the positive and negative vial lot numbers for SARS-CoV-2 Ag LQCs within batch 2002204017, which should have been assigned SARS-CoV-2 Ag lot numbers resulting in an error message and preventing use of the LQC

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality Control Kit Catalog #: L016080109002 (EUA) The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip. The Quality Controls provide users with assurance that the device is performing within specification

Get recall alerts

Free email alert whenever LumiraDx has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: LumiraDx